[1] PHILLIPS J M,PARISH N M,BLAND C,et al.Type 1 diabetes development requires both CD4 + and CD8 + T cells and can be reversed by non-depleting antibodies targeting both cell populations[J].Rev Diabet Stud,2009,6(2): 97-103.DOI: 10.1900/RDS.2009.6.97. [2] SHAMIN L,CLAUDINE J,CHANTAL B,et al.Potential Role of IL-17-producing iNKT cells in type 1 diabetes [J].PLoS One,2014,9(4): e96151.DOI: 10.1371/journal.pone.0096151. [3] DAVID N,NORA A,MATTNER J.Mechanisms of innate lymphoid cell and natural killer T cell activation during mucosal inflammation[J].J Immunol Res,2014,2014: 546596.DOI: 10.1155/2014/546596. [4] BRENNAN P J,BRIGL M,BRENNER M B.Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions [J].Nat Rev Immunol,2013,13(2):101-117.DOI: 10.1038/nri3369. [5] GAPIN L.Development of invariant natural killer T cells [J].Curr Opin Immunol,2016,39:68-74.DOI:10.1016/j.coi.2016.01.001. [6] AGUIAR C F,NAFFAH-DE-SOUZA C,CASTOLDI A,et al.Administration of α-Galactosylceramide Improves Adenine-Induced Renal Injury [J].Mol Med,2015,21:553-562.DOI: 10.2119/molmed.2014.00090. [7] FICHTNER A S,PALETTA D,STARICK L,et al.Function and expression of CD1d and invariant natural killer T-cell receptor in the cotton rat(Sigmodon hispidus)[J].Immunology,2015,146(4):618-629.DOI: 10.1111/imm.12532. [8] TSAIH S W,PRESA M,KHAJA S,et al.A locus on mouse Chromosome 13 inversely regulates CD1d expression and the development of invariant natural killer T-cells [J].Genes Immun,2015,16(3):221-230.DOI: 10.1038/gene.2014.81. [9] BERGA-BOLAOS R,SHARMA A,STEINKE F C,et al.β-Catenin is required for the differentiation of iNKT2 and iNKT17 cells that augment IL-25-dependent lung inflammation [J].BMC Immunol,2015,16(1):62.DOI: 10.1186/s12865-015-0121-0. [10] WINGENDER G,SAG D,KRONENBERG M,et al.NKT10 cells: a novel iNKT cell subset [J].Oncotarget,2015,6(29):26552-26553.DOI: 10.18632/oncotarget.5270. [11] HU T,WANG H,SIMMONS A,et al.Increased level of E protein activity during invariant NKT development promotes differentiation of invariant NKT2 and invariant NKT17 subsets [J].J Immunol,2013,191(10):5065-5073.DOI: 10.4049/jimmunol.1301546. [12] SIMONI Y,GAUTRON A S,BEAUDOIN L,et al.NOD mice contain an elevated frequency of iNKT17 cells that exacerbate diabetes [J].Eur J Immunol,2011,41(12):3574-3585.DOI: 10.1002/eji.201141751. [13] CHEN Y G,CHOISY-ROSSI C M,HOLL T M,et al.Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes [J].J Immunol,2005,174: 1196-1204.DOI: 10.4049/jimmunol.174.3.1196. [14] JAAKKOLA,JALKANEN S,HANMINEN A,et al.Diabetogenic T cells are primed both in pancreatic and gut-associated lymph nodes in NOD mice [J].Eur J Immunol,2003,33:3255-3264.DOI:10.1002/eji.200324405. [15] CHEN Y G,TSAIH S W,SERREZE D V,et al.Genetic control of murine invariant natural killer T-cell development dynamically differs dependent on the examined tissue type [J].Genes Immun,2012,13(2):164-174.DOI: 10.1038/gene.2011.68. [16] SIMONI Y,DIANA J,GHAZARIAN L,et al.Therapeutic manipulation of natural killer(NK)T cells in autoimmunity: are we close to reality? [J].Clin Exp Immunol,2013,171(1): 8-19.DOI: 10.1111/j.1365-2249.2012.04625.x. [17] DALAM L,Mi Q S,HUSSAIN S,et al.Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells [J].J Immunol,2006,177(6):3695-3704.DOI: 10.4049/jimmunol.177.6.3695. [18] DIANA J,BREZAR V,BEAUDOIN L,et al.Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay [J].J Exp Med,2011,208(4):729-745.DOI: 10.1084/jem.20101692. [19] GHAZARIAN L,DIANA J,BEAUDOIN L,et al.Protection against type 1 diabetes upon Coxsackievirus B4 infection and iNKT-cell stimulation: role of suppressive macrophages [J].Diabetes,2013,62(11):3785-3796.DOI: 10.2337/db12-0958. [20] BEAUDOIN L,DIANA J,GHAZARIAN L,et al.Plasmacytoid dendritic cells license regulatory T cells,upon iNKT-cell stimulation,to prevent autoimmune diabetes [J].Eur J Immunol,2014,44(5):1454-1466.DOI: 10.1002/eji.201343910. [21] SCHEUPLEIN F,LAMONT D J,POYNTER M,et al.Invariant Monoclonal Antibody NKT14: A Novel Tool to Manipulate iNKT Cell Function In Vivo [J].PLoS One,2015,10(10):e0140729.DOI: 10.1371/journal.pone.0140729. [22] MAGALHAES I,KIAF B,LEHUEN A,et al.iNKT and MAIT Cell Alterations in Diabetes [J].Front Immunol,2015,6:341.DOI: 10.3389/fimmu.2015.00341. [23] VALLOIS D,GAGNERAULT M C,AVNER P,et al.Influence of a non-NK complex region of chromosome 6 on CD4+ invariant NK T cell homeostasis [J].Immunol,2008,181(3):1753-1759.DOI:10.4049/jimmunol.181.3.1753. [24] CAIELLI S,SORINI C,FALCONE M.The dangerous liaison between iNKT cells and dendritic cells: does it prevent or promote autoimmune diseases? [J].Autoimmunity,2011,44(1):11-22. |